title: Ibrutinib: Implications for Use in the Treatment of Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia.
authors.affiliation: 1The Ohio State University-Arthur G. James Cancer Hospital, Columbus, Ohio; 2Whittingham Cancer Center, Norwalk Hospital, Norwalk, Connecticut; 3TriHealth Cancer Institute, Cincinnati, Ohio; 4MD Anderson Cancer Center, Houston, Texas.
authors.forename: Gretchen Anne
authors.initials: GA
authors.lastname: McNally
authors.affiliation: 1The Ohio State University-Arthur G. James Cancer Hospital, Columbus, Ohio; 2Whittingham Cancer Center, Norwalk Hospital, Norwalk, Connecticut; 3TriHealth Cancer Institute, Cincinnati, Ohio; 4MD Anderson Cancer Center, Houston, Texas.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Long
authors.affiliation: 1The Ohio State University-Arthur G. James Cancer Hospital, Columbus, Ohio; 2Whittingham Cancer Center, Norwalk Hospital, Norwalk, Connecticut; 3TriHealth Cancer Institute, Cincinnati, Ohio; 4MD Anderson Cancer Center, Houston, Texas.
authors.forename: Lynne R
authors.initials: LR
authors.lastname: Brophy
authors.affiliation: 1The Ohio State University-Arthur G. James Cancer Hospital, Columbus, Ohio; 2Whittingham Cancer Center, Norwalk Hospital, Norwalk, Connecticut; 3TriHealth Cancer Institute, Cincinnati, Ohio; 4MD Anderson Cancer Center, Houston, Texas.
authors.forename: Maria R
authors.initials: MR
authors.lastname: Badillo